|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.92 USD | -4.17% |
|
-8.85% | -42.80% |
| 11-13 | Instil Bio Q3 net loss per share narrows | RE |
| 11-13 | Instil Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
| Capitalization | 74.06M 63.66M 59.64M 55.59M 103M 6.67B 112M 698M 269M 3.15B 278M 272M 11.51B | P/E ratio 2025 * |
-0.92x | P/E ratio 2026 * | -0.88x |
|---|---|---|---|---|---|
| Enterprise value | 74.06M 63.66M 59.64M 55.59M 103M 6.67B 112M 698M 269M 3.15B 278M 272M 11.51B | EV / Sales 2025 * |
-
| EV / Sales 2026 * | - |
| Free-Float |
87.18% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
More recommendations
More press releases
| 1 day | -4.17% | ||
| 1 week | -8.85% | ||
| Current month | -14.42% | ||
| 1 month | -27.97% | ||
| 3 months | -63.98% | ||
| 6 months | -68.26% | ||
| Current year | -42.80% |
| 1 week | 10.7 |  | 12.62 |
| 1 month | 10.7 | | 16 |
| Current year | 10.7 | | 42.79 |
| 1 year | 10.7 | | 42.79 |
| 3 years | 6.07 | | 92 |
| 5 years | 6.07 | | 589.8 |
| 10 years | 6.07 | | 589.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bronson Crouch
CEO | Chief Executive Officer | 52 | 31/10/2018 |
Sandeep Laumas
DFI | Director of Finance/CFO | 57 | 31/01/2021 |
Jamie Freedman
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Bronson Crouch
CHM | Chairman | 52 | 31/10/2018 |
George Matcham
BRD | Director/Board Member | 73 | 31/08/2018 |
| Director/Board Member | 50 | 30/06/2020 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0% | 293,477 M€ | +8.97% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -4.17% | -8.85% | -61.55% | -56.32% | 77.28M | |
| -0.95% | -0.66% | +2.80% | +7.78% | 48.03B | |
| +0.41% | -2.57% | +11.16% | +3.73% | 38.3B | |
| -2.56% | -5.21% | +62.19% | +59.96% | 36.67B | |
| +0.38% | -1.03% | +9.38% | +19.64% | 27.13B | |
| +0.61% | -9.64% | +58.27% | +162.26% | 15.35B | |
| +1.48% | +2.66% | +65.06% | +211.95% | 15.17B | |
| +0.05% | +1.21% | -13.35% | -12.77% | 14.19B | |
| +0.43% | -0.71% | +32.20% | - | 13.58B | |
| -0.16% | -1.23% | +119.87% | +102.58% | 13.25B | |
| Average | -0.73% | -2.17% | +28.60% | +55.42% | 22.17B | |
| Weighted average by Cap. | -0.54% | -1.75% | +30.71% | +48.65% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -79.3M -68.16M -63.85M -59.52M -110M -7.14B -120M -747M -288M -3.37B -298M -291M -12.32B | -73.7M -63.35M -59.35M -55.32M -102M -6.63B -111M -694M -268M -3.13B -277M -271M -11.45B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
14
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 10.92 $ | -4.17% | 50,581 |
| 04/12/25 | 11.40 $ | -0.83% | 67,402 |
| 03/12/25 | 11.49 $ | +6.59% | 54,850 |
| 02/12/25 | 10.78 $ | -5.77% | 90,943 |
| 01/12/25 | 11.44 $ | -10.34% | 50,540 |
Delayed Quote Nasdaq, December 05, 2025 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
10.92USD
Average target price
118.67USD
Spread / Average Target
+986.69%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TIL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition